32 results on '"Cars, Otto"'
Search Results
2. Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
3. Antibiotic research and development: business as usual?
4. Antibiotic Resistance — Problems, Progress, and Prospects
5. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing
6. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model
7. 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards
8. Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae
9. Tackling antibiotic resistance
10. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS
11. Alcohol-based hand-disinfection reduced childrenʼs absence from Swedish day care centers
12. Estimation of Cefuroxime Dosage Using Pharmacodynamic Targets, MIC Distributions, and Minimization of a Risk Function
13. Meeting the challenge of antibiotic resistance
14. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model
15. Tissue concentrations: do we ever learn?
16. Dose-related selection of fluoroquinolone-resistant Escherichia coli
17. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model
18. A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function
19. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration
20. Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992–2002
21. Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli
22. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update
23. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens
24. Defined daily doses of antimicrobials reflect antimicrobial prescriptions in ambulatory care
25. High Antibiotic Susceptibility among Bacterial Pathogens in Swedish ICUs: Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility
26. Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage
27. Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers
28. Weekly Antibiotic Prescribing and Influenza Activity in Sweden: A Study throughout Five Influenza Seasons
29. Antimicrobial resistance: Is a major threat to public health
30. Control of antimicrobial resistance: time for action: The essentials of control are already well known
31. Colonisation and Infection with Resistant Gram-Positive Cocci: Epidemiology and Risk Factors
32. Oral Empiric Treatment of Community-Acquired Pneumonia*: A Multicenter, Double-blind, Randomized Study Comparing Sparfloxacin With Roxithromycin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.